Chilblains, also known as perniosis, are a localized inflammatory skin condition resulting from abnormal vascular response to cold, non-freezing temperatures. They most commonly affect the toes, fingers, ears, and nose. In the foot, chilblains can cause significant discomfort, impair mobility, and increase the risk of secondary infection—especially in vulnerable populations such as the elderly or those with pre-existing vascular compromise. Effective management requires a combination of prevention, symptomatic relief, and, where necessary, medical intervention.
Understanding Chilblains
Chilblains develop when the skin is exposed to cold and humidity, leading to vasoconstriction followed by a rapid rewarming that causes blood vessels to leak fluid into surrounding tissues. This results in redness, swelling, itching, and sometimes blistering or ulceration. Individuals with poor peripheral circulation, such as those with diabetes or Raynaud’s phenomenon, are particularly susceptible.
Clinical Presentation
Chilblains typically present as:
- Red or purple patches on the toes or feet
- Swelling and tenderness
- Intense itching or burning
- Blistering or ulceration in severe cases
Diagnosis is usually clinical, based on history and presentation, but other conditions such as frostbite, vasculitis, or connective tissue disorders should be excluded if symptoms are atypical or persistent.
Treatment Strategies
1. Prevention
The cornerstone of chilblain management is prevention:
- Keep feet warm and dry: Advise wearing wool or moisture-wicking socks and insulated footwear. Avoid tight shoes that may restrict circulation.
- Gradual temperature changes: Avoid rapid warming of cold feet (e.g., placing feet directly on a heater), as this can exacerbate vascular leakage.
- Environmental control: Encourage patients to avoid prolonged exposure to cold and damp environments.
2. Symptomatic Relief
For patients presenting with chilblains, symptomatic relief is essential:
- Topical corticosteroids: Mild to moderate potency corticosteroid creams (e.g., hydrocortisone 1%) can reduce inflammation, itching, and discomfort.
- Emollients: Regular application of moisturising creams helps maintain skin integrity and prevent cracking.
- Gentle warming: Encourage gradual rewarming with warm (not hot) water or gentle massage to restore circulation.
- Pain management: Paracetamol or non-steroidal anti-inflammatory drugs (NSAIDs) may be used for pain relief.
3. Promote Healing
- Wound care: If blistering or ulceration occurs, maintain a clean, moist wound environment with non-adhesive dressings. Monitor for signs of infection.
- Infection control: If secondary bacterial infection is suspected (increased redness, pus, or systemic symptoms), initiate appropriate topical or oral antibiotics as indicated.
- Avoid trauma: Advise patients to avoid scratching or rubbing the affected area, as this can worsen tissue damage.
4. Address Underlying Factors
- Vascular health: Assess for underlying vascular insufficiency, diabetes, or autoimmune disorders, especially in recurrent or severe cases.
- Smoking cessation: Encourage cessation of smoking, as nicotine contributes to vasoconstriction and impairs healing.
- Medications: In recurrent or severe cases, vasodilators such as nifedipine may be prescribed under medical supervision to improve blood flow.
5. Patient Education
Educate patients about the risk factors, early signs, and self-care strategies to prevent recurrence. Clear communication is crucial for compliance and long-term management.
Special Considerations
High-Risk Populations
- Diabetics: Extra vigilance is needed due to increased risk of neuropathy and infection. Regular foot checks and prompt management of any lesions are essential.
- Elderly or immobile patients: Ensure adequate foot protection and regular monitoring, as reduced mobility increases risk.
When to Refer
Referral to a podiatrist or specialist is warranted if:
- Ulceration is severe or not healing
- There are signs of systemic infection
- There is suspicion of underlying vascular disease or autoimmune disorder
Prognosis
With prompt and effective management, chilblains typically resolve within 2–3 weeks. Recurrence is common in cold climates or if preventive measures are not adopted. Chronic or recurrent chilblains may indicate an underlying systemic condition requiring further investigation.
Chilblains of the foot are a preventable and manageable condition with the right approach. Prevention through adequate warmth and moisture control is paramount. For those affected, a combination of symptomatic relief, wound care, and patient education underpins effective treatment. Clinicians should remain vigilant for complications and underlying comorbidities, particularly in high-risk groups. By adopting a comprehensive, patient-centered strategy, the burden of chilblains can be significantly reduced, allowing individuals to maintain mobility and quality of life throughout the colder months.
